1.Recent advances in enzyme assays using fluoremetry.
Yanlong XING ; Xiangzhao MAO ; Shu WANG ; Hualei WANG ; Dongzhi WEI
Chinese Journal of Biotechnology 2009;25(12):1765-1769
Enzymes play such a pivotal role in cellular metabolism that enzyme assays are important for bio-engineering, disease diagnoses and drug discovery. Among the reported methods, fluoremetry has attracted more and more attention due to its high sensitivity and possibility of continuous dynamic monitoring. The recent progresses and applications in enzyme assays using fluorescent probes were reviewed. Different methods were classified into direct fluorescence detection and indirect fluorescence detection according to their labeled substrates and detection mechanisms. Our writing purpose is to provide the readers with a flavor of the kinds of tools and strategies available in enzyme assays with fluorescent probes. Also, the research situation and prospects were disucssed
Animals
;
Enzyme Assays
;
methods
;
trends
;
Fluorescent Dyes
;
Fluorometry
;
methods
;
Humans
;
Microscopy, Fluorescence
2.Rapid and high throughput measurement of lipase thermo-stability through ANS fluorescence signal assay.
Weizong FENG ; Junhan LIN ; Shaoli CAI ; Youtu ZOU ; Guoren CHEN ; Ping HUANG ; Yajing LIN ; Bingbing WANG ; Lin LIN
Chinese Journal of Biotechnology 2011;27(4):584-591
We have developed a rapid and high throughput lipase-ANS (8-Anilino-l-naphthalenesulfonic acid) assay to evaluate the thermo-stability of lipases based on the ANS fluorescence signal's increasing and shifting when this small fluorescence probes binds to lipase. The testing lipase samples were incubated at a temperature range of 25 degrees C to 65 degrees C for 30 min before mixed with ANS solution (0.20 mg/mL lipase and 0.05 mmol/L ANS in the buffer of 20 mmol/L Tris-HCl, 100 mmol/L NaCl, pH 7.2) in a cuvette or microplate. Fluorescence signals of the samples were measured at EX 378 nm, EM 465 nm with a fluorescence photometer or a plate reader, and Tm was calculated with the software of GraphPad Prism5.0. The Tm values of several mutants of Penicillium expansum lipase (PEL) were measured with this ANS assay and conventional method simultaneously and the results show that Tm values are comparative and consistent between these methods, suggesting that the lipase-ANS assay is a reliable, rapid and high throughput method for lipase thermo-stability measurement.
Anilino Naphthalenesulfonates
;
chemistry
;
Enzyme Stability
;
High-Throughput Screening Assays
;
methods
;
Hot Temperature
;
Lipase
;
metabolism
;
Spectrometry, Fluorescence
3.Determination of angiotensin I-converting enzyme activity in equine blood: lack of agreement between methods of analysis.
Maria Fernanda de M COSTA ; Adriana K CARMONA ; Marcio F M ALVES ; Timothy M RYAN ; Helen M DAVIES ; Garry A ANDERSON ; Ron F SLOCOMBE
Journal of Veterinary Science 2011;12(1):21-25
Angiotensin-I converting enzyme (ACE) is a key regulator of blood pressure, electrolytes and fluid homeostasis through conversion of angiotensin I into angiotensin II. Recently, a genetic polymorphism of the ACE gene, which accounts for 47% of the variation of ACE activity in blood, has been advocated as a biomarker of athletic aptitude. Different methods of analysis and determination of ACE activity in plasma have been used in human and equine research without a consensus of a "gold standard" method. Different methods have often been used interchangeably or cited as being comparable in the existing literature; however, the actual agreement between assays has not been investigated. Therefore, in this study, we evaluated the level of agreement between three different assays using equine plasma obtained from 29 horses. Two spectrophotometric assays using Furylacryloyl-phenylalanyl-glycyl-glycine as substrate and one fluorimetric assay utilizing o-aminobenzoic acid-FRK-(Dnp)P-OH were employed. The results revealed that the measurements from the different assays were not in agreement, indicating that the methods should not be used interchangeably for measurement of equine ACE activity. Rather, a single method of analysis should be adopted to achieve comparable results and critical appraisal of the literature is needed when attempting to compare results obtained from different assays.
Animals
;
Enzyme Assays/*methods
;
Female
;
Fluorometry/*methods
;
Horses/blood/genetics/*metabolism
;
Male
;
Oligopeptides/pharmacology
;
Peptidyl-Dipeptidase A/blood/genetics/*metabolism
;
Polymorphism, Genetic
;
Reference Values
;
Spectrophotometry/*methods
4.Rapid testing on drug susceptibility of Mycobacterium tuberculosis with nitrate reducrase assay.
Zhong-Quan LIU ; Chuan-You LI ; Xiao-You CHEN ; Xi CHEN ; Yu MA
Chinese Journal of Epidemiology 2007;28(7):697-699
OBJECTIVETo establish a rapid method for testing drug sussceptibility on Mycobacterium tuberculosis.
METHODSTaking absolute Concentration method for drug susceptibility testing of M. tuberculosis as the "gold standard", we examined the drug-resistant of M. tuberculosis strain with nitrate reducrase assay (NRA) and the drug-resistant of M. tuberculosis germ in sputum with NRA.
RESULTSNRA and absolute concentration method was basically comparable with NRA susceptibility as 96.5% and the specificity was 100%, When comparing with traditional absolute concentration method, NRA could shorten the time about 3 weeks. Using NRA to test the drug-resistant of M. tuberculosis germ in sputum, its susceptibility was more than 66.7% and specificity was 100%, within 10-20 days.
CONCLUSIONNRA could be used as a rapid drug susceptibility testing on M. tuberculosis.
Anti-Bacterial Agents ; pharmacology ; Drug Resistance, Bacterial ; Enzyme Assays ; methods ; Humans ; Microbial Sensitivity Tests ; methods ; Mycobacterium tuberculosis ; drug effects ; pathogenicity ; Nitrate Reductase ; metabolism ; Sputum ; microbiology
5.Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population.
Minje HAN ; Sun Hee JUN ; Sang Hoon SONG ; Kyoung Un PARK ; Jin Q KIM ; Junghan SONG
The Korean Journal of Laboratory Medicine 2011;31(4):250-256
BACKGROUND: We evaluated the performance of multiplex tandem mass spectrometry (MS/MS) in newborn screening for detection of 6 lysosomal storage disorders (LSDs), namely, Niemann-Pick A/B, Krabbe, Gaucher, Fabry, and Pompe diseases and Hurler syndrome. METHODS: We revised the conditions and procedures of multiplex enzyme assay for the MS/MS analysis and determined the precision of our enzyme assay and the effects of sample amounts and incubation time on the results. We also measured the degree of correlation between the enzyme activities in the dried blood spots (DBSs) and those in the leukocytes. DBSs of 211 normal newborns and 13 newborns with various LSDs were analyzed using our revised methods. RESULTS: The intra- and inter-assay precisions were 2.9-18.7% and 8.1-18.1%, respectively. The amount of product obtained was proportional to the DBS eluate volume, but a slight flattening was observed in the product vs. sample volume curve at higher sample volumes. For each enzyme assay, the amount of product obtained increased linearly with the incubation period (range, 0-24 hr). Passing and Bablok regression analysis revealed that the enzyme activities in the DBSs and those in the leukocytes were favorably correlated. The enzyme activities measured in the DBSs were consistently lower in patients with LSDs than in normal newborns. CONCLUSIONS: The performance of our revised techniques for MS/MS detection and enzyme assays was of the generally acceptable standard. To our knowledge, this is the first report on the use of MS/MS for newborn screening of LSDs in an Asian population.
Dried Blood Spot Testing
;
Enzyme Assays
;
Enzymes/blood
;
Humans
;
Infant, Newborn
;
Leukocytes/enzymology
;
Lysosomal Storage Diseases/*diagnosis
;
Republic of Korea
;
Tandem Mass Spectrometry/*methods
;
Time Factors
6.High-throughput screening for hamster chymase 2 inhibitors.
Shou-Bao WANG ; Xiao-Ming ZHU ; Feng GAO ; Xiao-Bin PANG ; Guan-Hua DU
Acta Pharmaceutica Sinica 2012;47(2):168-173
To screen potential hamster chymase 2 inhibitors, a high-throughput screening (HTS) model was established. Recombinant hamster chymase 2 with active form was cloned and expressed in E. coli. The HTS model with total volume of 50 microL in 384-well microplate was based on fluorescence analysis and was proved sensitive as well as specific (Z' = 0.84). A total of 40 080 samples (including 28 060 compounds and 12 020 natural products) were screened, and 613 samples with inhibition greater than 90% were selected for further rescreening. Finally, compounds J16647 and J16648 were identified with high inhibitory activity on chymase 2, and whose IC50 values were 0.823 and 0.690 micromol x L(-1), respectively.
Animals
;
Chymases
;
analysis
;
antagonists & inhibitors
;
Cricetinae
;
Enzyme Inhibitors
;
analysis
;
pharmacology
;
Escherichia coli
;
metabolism
;
High-Throughput Screening Assays
;
methods
;
Inhibitory Concentration 50
;
Rats
;
Structure-Activity Relationship
7.Determination of biological activity of extract from hirudo by N-benzoyl-L-arginine ethyl ester.
Shixia GUAN ; Can PENG ; Haigang LI ; Shuqin XU ; Zhongwen YUAN
China Journal of Chinese Materia Medica 2010;35(15):1990-1992
As a potent anticoagulant, leech a traditional Chinese medicine, has become increasing topics. Hirudin, which is the primary effective component in leech, is a specific and efficient inhibitor of thrombin, mainly used in prevention and treatment of thrombus on the clinic practice. However, there is still no accurate and convenient method reported about the determination of it's biological activity. This paper reported a method for the determination of the biological activity the of extract from hirudo. The extra thrombin, which was not inhibited by hirudin in the extract from hirudo, reacted with N-benzoyl-L-arginine ethyl ester and was determined. The biological activity of the hirudo extract was determined, indirectly. The linear of calibration curve and accuracy were both perfect, the method was accurate and reliable.
Animals
;
Arginine
;
analogs & derivatives
;
analysis
;
Biological Factors
;
analysis
;
isolation & purification
;
pharmacology
;
Enzyme Assays
;
methods
;
Enzyme Inhibitors
;
analysis
;
isolation & purification
;
pharmacology
;
Hirudins
;
analysis
;
isolation & purification
;
pharmacology
;
Hirudo medicinalis
;
chemistry
;
Thrombin
;
analysis
;
antagonists & inhibitors
8.High-throughput screening of human soluble epoxide hydrolase inhibitors.
Shou-Bao WANG ; Jing GUO ; Xiao-Ming YU ; Guan-Hua DU
Acta Pharmaceutica Sinica 2010;45(11):1367-1372
To screen potential human soluble epoxide hydrolase (hsEH) inhibitors, a high-throughput screening model in 384-well microplate with total volume of 50 microL was established. Recombinant hsEH was cloned and expressed in E. coli. and its specific substrate PHOME was synthesized. The HTS model was based on fluorescence analysis with enhanced sensitivity and specificity (Z' = 0.65). A total of 47 360 samples (including 25 040 compounds and 22 320 natural products) were screened, of which 950 samples with inhibition greater than 80% were selected for further rescreening. Finally, two compounds with high inhibitory activity were identified, whose IC50 value were 8.56 and 4.31 micromol x L(-1), separately. The results indicated that the method was stable, sensitive, reproducible and also suitable for high-throughput screening.
Drug Evaluation, Preclinical
;
methods
;
Enzyme Inhibitors
;
analysis
;
chemistry
;
Epoxide Hydrolases
;
antagonists & inhibitors
;
chemistry
;
metabolism
;
Escherichia coli
;
metabolism
;
High-Throughput Screening Assays
;
methods
;
Inhibitory Concentration 50
;
Recombinant Proteins
;
metabolism
;
Reproducibility of Results
;
Sensitivity and Specificity
;
Spectrometry, Fluorescence
;
methods
;
Substrate Specificity
9.High-throughput screening of human soluble protein tyrosine phosphatase 1B inhibitors.
Xiao-bin PANG ; Xin-mei XIE ; Shou-bao WANG ; Guan-hua DU
Acta Pharmaceutica Sinica 2011;46(9):1058-1064
To screen potential human soluble protein tyrosine phosphatase 1B (PTP1B) inhibitors, a high-throughput screening (HTS) model in 384-well microplate with total volume of 50 microL was established. Recombinant PTP1B was cloned and expressed in E. coli. with its specific substrate 4-nitrophenyl phosphate disodium salt hexahydrate (PNPP). The HTS model was based on enzyme reaction rate with enhanced sensitivity and specificity (Z' = 0.78). A total of 24,240 samples were screened, among them 80 samples with inhibition greater than 70% were selected for further rescreening. Finally, six compounds with high inhibitory activity were identified, whose IC50 values were 21.58, 18.39, 15.37, 11.92, 37.27, and 36.61 microg x mL(-1), separately. The results indicated that the method was stable, sensitive, reproducible and also suitable for high-throughput screening.
Drug Evaluation, Preclinical
;
methods
;
Enzyme Inhibitors
;
analysis
;
pharmacology
;
Escherichia coli
;
metabolism
;
High-Throughput Screening Assays
;
methods
;
Humans
;
Inhibitory Concentration 50
;
Protein Tyrosine Phosphatase, Non-Receptor Type 1
;
antagonists & inhibitors
;
metabolism
;
Sensitivity and Specificity
;
Vanadates
;
pharmacology
10.Clinical application of a method for evaluating von Willebrand factor cleaving protease activity.
Fa-Quan LIN ; Ming-Fen LI ; Qian LIU ; Zhao-Yan LI
Journal of Southern Medical University 2007;27(8):1176-1179
OBJECTIVETo establish a method for evaluating the activity of von Willebrand factor cleaving protease (vWF-cp) and evaluate its clinical application.
METHODSPurified von Willebrand factor polymer was isolated by gel filtration from human fresh-frozen plasma as the enzyme substrate. SDS-PAGE, Western blotting, and luminographic detection were used to evaluate vWF-cp activity of 60 healthy adults, 28 patients with cerebral infarction (CI) and 7 with thrombotic thrombocytopenic purpura (TTP).
RESULTSIn the subjects involved, the method for evaluating vWF-cp activity had intra- and inter-batch coefficient of variation(CV) of 4.81% (n=8) and 8.63% (n=6), respectively. According to this method, the plasma vWF-cp activity in the 60 healthy adults was significantly higher than that in the CI patients [(86.53-/+17.49)% vs (77.15-/+16.72)%, P<0.05]. In TTP patients before plasma replacement, the vWF-cp activity was (9.06-/+7.17)% and increased significantly to (47.00-/+6.27)% 24 h after plasma replacement, respectively, but still significantly lower than that of healthy adults (P<0.01), whereas in the convalescent stage, the activity approached the normal level [(83.18-/+8.83)%, P>0.05].
CONCLUSIONSAccording to the described method, which allows accurate vWF-cp activity measurement with good sensitivity, specificity and reproducibility, vWF-cp activity is lower in CI patients and even more so in TTP patients than that of healthy adults. Plasma replacement can effectively increase the vWF-cp activity in TTP patients.
ADAM Proteins ; blood ; metabolism ; ADAMTS13 Protein ; Adult ; Animals ; Cerebral Infarction ; blood ; enzymology ; Enzyme Assays ; methods ; Female ; Humans ; Male ; Middle Aged ; Purpura, Thrombotic Thrombocytopenic ; blood ; enzymology ; Reproducibility of Results ; Substrate Specificity